rMark Bio
Developer of a business intelligence software designed to accelerate innovation, collaboration and scientific discovery for life sciences. The company's software provides an analytics platform for pharmaceutical companies to reduce human and financial capital to identify academic partners and increase the scalability of academic outreach efforts, enabling users to analyze global healthcare data in-conjunction with internal clinical research data to optimize partnership and engagement strategies across the life-cycle of a product for healthcare industries.
News
- Acquisition • Apr 27, 2021 | Within3 acquired rMark Bio for an undisclosed amount
- News • Apr 27, 2021 | Within3 — Within3 Announces Acquisition of rMark Bio™
- News • Oct 30, 2020 | Yahoo News — CerraCap Ventures Invests in Life Science AI Company rMark Bio, Inc.
- Funding Round • Oct 30, 2020 | rMark Bio raised an undisclosed amount / Series Unknown from CerraCap Ventures
- Funding Round • Oct 13, 2020 | rMark Bio raised $2,772,223 / Series Unknown
- News • Aug 19, 2020 | Odessa American — rMark Bio Appoints Industry Thought Leaders and Executives to Advisory Board
- News • Feb 7, 2019 | PE HUB — AI life sciences company rMark Bio gathers $1.5 mln seed
- Funding Round • Feb 7, 2019 | rMark Bio raised $1,500,000 / Seed from Lincoln Park Capital Fund and 4 other investors
- Funding Round • Sep 10, 2018 | rMark Bio raised $1,769,665 / Seed from Scott Garber
- Funding Round • Feb 5, 2018 | rMark Bio raised $100,000 / Seed
- Funding Round • Apr 29, 2016 | rMark Bio raised an undisclosed amount / Non Equity Assistance
- Funding Round • Nov 1, 2015 | rMark Bio raised $429,000 / Convertible Note
